The microbiome sequencing services market is expected to grow at 21.5 % CAGR from 2023 to 2030. It is expected to reach above USD 10656.3 million by 2030 from USD 2726.29 million in 2023.
The study of directly retrieved genetic material is referred to as microbiome sequencing. Microbiome sequencing uses human biodata to hydrate the sickness using several approaches. In order to comprehend human microbes and their function in health and disease, this field of study examines the microbes that live in the human gut. Previously, to examine an individual's phenotype and genotype, traditional microbiological procedures were applied by obtaining samples from the individual's skin, blood, or stool. Human microbiome data is produced using techniques like 21st-century testing as a result of technological advancement.
One of the key factors fueling the expansion of the market for microbiome sequencing services is the increased global attention being paid to human microbiome therapy. Technology advancements in the fields of DNA research, genomics, metabolomics, and microbiome processing, as well as the use of the human microbiome as a newly validated target for drug development, have all contributed to the acceleration of the market's expansion. Furthermore, the market for microbiome sequencing services benefits from the growth of the biotechnology sector, an increase in healthcare spending, and advances in the life sciences. Additionally, during the forecast period of 2021 to 2029, the market players would benefit from an increase in partnerships and investigational new drug (IND) requirements for faucal microbiota.
The increase in research and development organizations in the biological area, growing studies over genomics, and rising chronic disorders are what are fueling the expansion of the global microbiome sequencing services market. Additionally, rising priority for early diagnosis as some diseases may have a complete cure when diagnosed at the starting stage is fueling the demand for the market, as well as rising government support through investments and rising spending on health care in urban areas.
There are some limitations and difficulties that will prevent the market from growing as a whole. The market's growth is being hampered by factors like a lack of operating system expertise, strict government regulations, and the relatively high cost of equipment installation and maintenance. These factors are anticipated to restrain the growth of the global Microbiome Sequencing Services industry. Analysis of the market can impede progress if there is a lack of innovation.
Numerous factors, including the rising frequency of chronic diseases, the expanding desire for personalized medicine and targeted therapies, and the rising investments in microbiome research, create potential prospects for the microbiome sequencing services market. Furthermore, the advent of fresh sequencing technologies and the expansion of uses outside of human health, including agricultural and environmental monitoring, are anticipated to fuel market expansion.
However, the COVID-19 pandemic has had a favorable effect on the market for outsourcing services for microbiome sequencing. Microbiome sequencing is often most common in two fields: pathology and cancer. It may be possible to determine the virus's existence and the host's reaction to COVID-19 by RNA sequencing. As a result, one of the key drivers boosting its rise in 2020 and beyond is the increasing use of microbiome sequencing methods during the COVID-19 pandemic.
ATTRIBUTE | DETAILS |
Study period | 2020-2030 |
Base year | 2022 |
Estimated year | 2023 |
Forecasted year | 2023-2030 |
Historical period | 2019-2021 |
Unit | Value (USD Million). |
Segmentation | By Technology, By Laboratory Type, By Research Type, By Application, By End User, By Region. |
By Technology
|
|
By Laboratory Type |
|
By Research Type |
|
By Application
|
|
By End User
|
|
By Region
|
|
The microbiome sequencing services market is expected to grow at 21.5 % CAGR from 2023 to 2030. It is expected to reach above USD 10656.3 million by 2030 from USD 2726.29 million in 2023.
North America held more than 45 % of the microbiome sequencing services market revenue share in 2022 and will witness expansion in the forecast period.
Technology advancements in the fields of DNA research, genomics, metabolomics, and microbiome processing, as well as the use of the human microbiome as a newly validated target for drug development, have all contributed to the acceleration of the market's expansion.
The microbiome sequencing services market key players includes Baseclear B.V., Clinical Microbiomics A/S, EPIBIOME, Merieux Nutrisciences Corporations, Metabiomics Corp., Microbiome Insights Inc., Microbiome Therapeutics LLC., MR DNA, Rancho Biosciences, Second Genome.
The segment involving shotgun sequencing is anticipated to experience the highest CAGR during the projection period. The reasons why shotgun sequencing is more rapid and affordable than alternative techniques.
With a market share of over 45.0% in 2022, North America was in the lead and is expected to continue to experience profitable growth during the projected period.
The microbiome sequencing services market is segmented based on technology, laboratory type, research type, application and end user.
[caption id="attachment_31148" align="aligncenter" width="1920"]The market is divided into sequencing by synthesis (SBS), sequencing by ligation (SBL), pyrosequencing, Sanger sequencing, and others based on technology. The segment that will experience the largest CAGR during the predicted period is sequencing by synthesis. The need for the section of technology known as sequencing by synthesis is increased by variables related to new technology and the general high demand for this technology.
[caption id="attachment_31149" align="aligncenter" width="1920"]The market is divided into wet labs and dry labs according to the type of laboratory. For the projection period, the wet lab research category is anticipated to experience the greatest CAGR. Wet labs, which are highly favored for microbiome sequencing services, enable us to conduct a variety of various types of investigations.
The market is divided into outsourced and internal segments based on the type of research. The market share that is most heavily weighted towards outsourcing. The reasons why outsourced R&D services are becoming more popular due to they are less expensive.
The market is divided into shotgun sequencing, targeted gene sequencing, RNA sequencing, whole genome sequencing, and others based on application. The segment involving shotgun sequencing is anticipated to experience the highest CAGR during the projection period. The reasons why shotgun sequencing is more rapid and affordable than alternative techniques.
The market is divided into academia/research institutes and pharmaceutical and biotechnology companies based on the end user. The section for pharmaceutical and biotechnology businesses is anticipated to experience the highest CAGR during the projection period. The demand for this market segment is being fueled by factors such the rise in biotechnology and pharmaceutical patents being awarded globally, as well as the huge increase in R&D investments.
[caption id="attachment_31150" align="aligncenter" width="1920"]The microbiome sequencing services market key players includes Baseclear B.V., Clinical Microbiomics A/S, EPIBIOME, Merieux Nutrisciences Corporations, Metabiomics Corp., Microbiome Insights Inc., Microbiome Therapeutics LLC., MR DNA, Rancho Biosciences, Second Genome.
17 October 2022: Clinical Microbiomics, a pioneering microbiome research company, announced its acquisition of MS-Omics, a leading metabolomics provider based in Denmark. 02 November 2021: Mérieux NutriSciences, a global player in food safety, quality and sustainability announced the full acquisition of Sher Consulting and Training, the market leader in premium quality, product safety, compliance, sustainability and environmental consulting services to support the Food and Feed Industry as well as a wide variety of other companies and organizations in Israel.The microbiome sequencing services market by region includes North America, Asia-Pacific (APAC), Europe, South America, and Middle East & Africa (MEA).
Due to the improving economic conditions in most of the world's nations, North America dominated the market for microbiome sequencing services. The market is growing primarily as a result of factors like funding and investments from the government, advanced technology, and rising research activities. Due to of government-sponsored genomics research and other initiatives, the United States is the leading country in this region.
Due to cutting-edge methods for disease diagnosis, the Asia Pacific region holds the second-highest market share position. With a high CAGR for the upcoming years, Asia-Pacific is the region that will expand the fastest. The emergence of novel methods for disease diagnosis and the continual advancement of sequencing technologies are both credited with this region's expansion.
[caption id="attachment_31151" align="aligncenter" width="1920"]Want to know more about the report or any specific requirement?
We asked them to research ‘ Equipment market’ all over the world, and their whole arrangement was helpful to us. thehealthanalytics.com insightful analysis and reports contributed to our current analysis and in creating a future strategy. Besides, the te
We asked them to research ‘Equipment market’ all over the world, and their whole arrangement was helpful to us. thehealthanalytics.com insightful analysis and reports contributed to our current analysis and in creating a future strategy. Besides, the te
Our Report’s database covers almost all topics of all regions over the Globe.
Tie ups with top publishers around the globe.
Complete pre and post sales support.
Complete secure payment process.